首页> 外文期刊>Bulletin of experimental biology and medicine >Quantitative Assay of B. pertussis Lipopolysaccharide
【24h】

Quantitative Assay of B. pertussis Lipopolysaccharide

机译:百日咳芽孢杆菌脂多糖的定量检测

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We studied activity of Bordetella pertussis LPS in the LAL test. The mean activity of various series of LPS preparations obtained from B. pertussis cells ranged from 1,950,000 to 2,940,000 endotoxin units/mu g (EU/mu g). Activity of the LPS preparation obtained from the culture medium supernatant was significantly higher (4,640,000 EU/mu g). Activity of the control standard E. coli 055:B5 LPS was 19,500 +/- 500 EU/mu g. These data indicate that activity of the obtained preparations of B. pertussis LPS in the LAL test is 100-200 times higher than activity of E. coli LPS used as a reference control. It was concluded that the results of the LAL test when assessing the permissible content of B. pertussis endotoxins require correction, probably by introducing a correction factor.
机译:我们在LAL试验中研究了百日咳博德特氏菌LPS的活性。从百日咳芽孢杆菌细胞中获得的各种系列LPS制剂的平均活性范围为1,950,000至2,940,000内毒素单位/μg(EU/μg)。从培养基上清液中获得的LPS制剂的活性显著更高(4,640,000 EU/μg)。对照标准大肠杆菌055:B5 LPS的活性为19,500 +/- 500 EU/mu g。这些数据表明,在LAL试验中获得的百日咳芽孢杆菌LPS制剂的活性比用作参考对照的大肠杆菌LPS的活性高100-200倍。得出的结论是,在评估百日咳芽孢杆菌内毒素的允许含量时,LAL测试的结果需要校正,可能是通过引入校正因子。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号